About Psoriasis

What exactly triggers psoriasis is unknown, but genetic, immunologic and provocative factors are known to play an important role.

It is believed that psoriasis is caused by the interaction of genetic and environmental factors. The knowledge of the inheritance of psoriasis within the family warn us of the significance of genetic factors in the development of the disease. Inheritance is polygonic, however population studies have focused on 1st, 6th, and 17th chromosomes as more susceptible gene sites important for the succession of psoriasis.

1/3

of all patients have shown signs of psoriatic disease at the age of 15.

Stress and respiratory infections

are the most important triggers for the development of psoriasis.

Clinical forms of psoriasis are plaque or vulgar psoriasis, pustular psoriasis, guttate psoriasis, erythrodermic psoriasis, palmoplantar and arthropathic psoriasis. The most common form of psoriasis is plaque psoriasis which is present with 80 to 90% of patients. Chronic psychiatric psoriasis (psoriasis vulgaris) is the most common clinical form of psoriasis manifested by the appearance of red focals covered with silver-white scales.

Psychiatric arthritis occurs in 30 to 40 percent of patients with psoriasis.

Psoriasis patients have a greater risk of developing: obesity, hypertension, cardiovascular disease, type 2 diabetes, myocardial infarction and depression.

Psoriasis is not a contagious disease.

Depending on the surface of the affected skin, psoriasis may be mild (up to 3%), moderate to severe (3-10%) and severe (> 10%). Mild forms of psoriasis are treated by local therapy (corticosteroid creams, D3 vitamin analogues, immunomodulators, retinoids), in medium heavy forms, local and phototherapy (UVB, PUVA) are used, and heavy forms are treated by systemic therapy (PUVA, conventional and biological drugs)

For patients suffering from all mild to medium types of psoriasis we propose treatment through application of Naftalan.

Contact us for a personalized psoriasis treatment.

Systematic therapy

can prevent the development of psoriasis and associated diseases and contribute to improving the quality of life. In order to achieve a longer lasting success in treating the disease, therapy should be individually tailored to include psychotherapy.